SinoMab BioScience Limited
HKEX:3681.HK
1.23 (HKD) • At close September 20, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) HKD.
| 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q2 | 2017 Q1 | 2016 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| -4.077 | 8.469 | -3.425 | 7.457 | 26.657 | 0 | 12.76 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Kosten van de omzet
| 0 | 0.943 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Brutowinst
| -4.077 | 7.526 | -3.425 | 7.457 | 26.657 | 0 | 12.76 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Brutowinstmarge
| 1 | 0.889 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Onderzoek- en ontwikkelingskosten
| 68.659 | 66.75 | 98.237 | 82.131 | 109.131 | 89.982 | 55.586 | 47.816 | 181.562 | 32.78 | 53.586 | 53.586 | 11.821 | 11.821 | 11.821 | 8.151 | 8.151 | 8.151 |
| Algemene en administratieve kosten
| 47.241 | 50.2 | 48.578 | 33.849 | 99.074 | 32.861 | 21.055 | 50.03 | 49.27 | 12.019 | 15.386 | 15.386 | 0.504 | 0.504 | 0.504 | 0.248 | 0.248 | 0.248 |
| Verkoop- en marketingkosten
| 0.174 | 0 | 0.164 | 0 | 1.465 | 0 | 0.925 | 0 | 0.255 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 47.415 | 50.2 | 48.742 | 33.849 | 100.539 | 32.861 | 21.98 | 50.03 | 49.525 | 12.019 | 15.386 | 15.386 | 0.504 | 0.504 | 0.504 | 0.248 | 0.248 | 0.248 |
| Overige kosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -137.943 | -137.943 | -137.943 | -26.024 | -26.024 | -26.024 | -18.297 | -18.297 | -18.297 |
| Bedrijfskosten
| 107.732 | 138.42 | 143.703 | 149.107 | 213.857 | 111.904 | 70.974 | 79.316 | 231.896 | 45.041 | -68.972 | -68.972 | -13.7 | -13.7 | -13.7 | -9.899 | -9.899 | -9.899 |
| Bedrijfsresultaat
| -120.151 | -109.424 | -150.404 | -108.523 | -183.013 | -122.843 | -64.806 | -97.846 | -231.087 | -44.799 | -68.972 | -68.972 | -13.7 | -13.7 | -13.7 | -9.899 | -9.899 | -9.899 |
| Bedrijfsresultaat ratio
| 29.47 | -12.921 | 43.914 | -14.553 | -6.865 | 0 | -5.079 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Totaal overige inkomsten en kosten netto
| 11.136 | -24.672 | 10.036 | -35.267 | 9.222 | 8.44 | 23.046 | 17.006 | 1.151 | -1.547 | -0.099 | -0.099 | -7.203 | -7.203 | -7.203 | -3.077 | -3.077 | -3.077 |
| Inkomen voor belasting
| -109.015 | -134.096 | -140.368 | -143.79 | -173.791 | -114.403 | -41.76 | -80.84 | -229.936 | -46.346 | -69.071 | -69.071 | -20.903 | -20.903 | -20.903 | -12.975 | -12.975 | -12.975 |
| Inkomen voor belasting ratio
| 26.739 | -15.834 | 40.983 | -19.283 | -6.52 | 0 | -3.273 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Belastingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.486 | 0.486 | 0.486 | -6.445 | -6.445 | -6.445 | -2.336 | -2.336 | -2.336 |
| Nettowinst
| -109.015 | -134.096 | -140.368 | -143.79 | -173.791 | -114.403 | -41.76 | -80.84 | -229.936 | -46.346 | -69.071 | -69.071 | -20.903 | -20.903 | -20.903 | -11.994 | -11.994 | -11.994 |
| Nettowinstmarge
| 26.739 | -15.834 | 40.983 | -19.283 | -6.52 | 0 | -3.273 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| WPA (Winst Per Aandeel)
| -0.11 | -0.13 | -0.14 | -0.15 | -0.18 | -0.11 | -0.042 | -0.08 | -0.26 | -0.058 | -0.083 | -0.083 | -0.021 | -0.021 | -0.021 | -0.012 | -0.012 | -0.012 |
| Verwaterde WPA
| -0.11 | -0.13 | -0.14 | -0.15 | -0.18 | -0.11 | -0.042 | -0.08 | -0.26 | -0.058 | -0.083 | -0.083 | -0.021 | -0.021 | -0.021 | -0.012 | -0.012 | -0.012 |
| EBITDA
| -108.334 | -102.107 | -140.484 | -103.81 | -175.607 | -120.822 | -62.376 | -96.234 | -229.76 | -43.89 | -66.364 | -66.364 | -18.81 | -18.81 | -18.81 | -10.024 | -10.024 | -10.024 |
| EBITDA ratio
| 26.572 | -12.057 | 41.017 | -13.921 | -6.588 | 0 | -4.888 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |